Mitosin and DNA Topoisomerase IIα: Two Novel Proliferation Markers in the Prognostication of Diffuse Astrocytoma Patient Survival-Reference-Cited by-同舟云学术

Mitosin and DNA Topoisomerase IIα: Two Novel Proliferation Markers in the Prognostication of Diffuse Astrocytoma Patient Survival

Published:2001-09 Issue:3 Volume:9 Page:207-214
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:Applied Immunohistochemistry & Molecular Morphology

Author:

Korkolopoulou Penelope,Patsouris Efstratios,Konstantinidou Anastasia E.,Christodoulou Panayota,Thomas-Tsagli Euphemia,Kouzelis Konstantinos,Angelidakis Dimitrios,Rologis Dimitrios,Davaris Panayotis

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference31 articles.

1. Prognostic implications of the proliferative potential of low-grade astrocytomas

2. Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression

3. The C Terminus of Mitosin Is Essential for Its Nuclear Localization, Centromere/Kinetochore Targeting, and Dimerization

4. Structure and function of type II DNA topoisomerases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas;Pathology - Research and Practice;2017-04

2. DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery;PLOS ONE;2017-03-16

3. Predictors and mechanisms of epilepsy occurrence in cerebral gliomas: What to look for in clinicopathology;Experimental and Molecular Pathology;2017-02

4. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III;Journal of Clinical Pathology;2015-07-17

5. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools;Journal of Clinical Neuroscience;2015-05